ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:

Dictionar de medicamente online

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dictionar medical online

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Puteti trimite articole cu tema medicala la
adresa de email

Solutie antistress!
Construieste poduri :)

Joc, Construieste podul, Cargo Bridge

Prinde pisica neagra :)
Prinde pisica neagra- Chat Noir - Flash game

Prostate Cancer Device Market Set To Triple In Asia And Latin America

The next five years will herald massive growth for minimally invasive prostate cancer devices in several emerging markets, with high intensity focused ultrasound (HIFU) technology leading the way. By 2010, the Asian and Latin American markets for brachytherapy seeds, cryoablation, and HIFU devices will gross over $25 million in revenue-more than 3 times the market value in 2005.

According to a recent report by Millennium Research Group, prostate cancer rates are rising sharply due to the aging population and changing lifestyles. In Asia, especially, a spike in prostate cancer cases is linked to a move away from traditional diets toward more Western fare. As rates of prostate cancer rise, so too will the interest in minimally invasive treatments. Much, if not most, of the growth in this sector will take place in rapidly industrializing countries in the Far East and Latin America.

Although it has yet to receive approval for commercial use in the US, HIFU treatment for prostate cancer is already tapping into a rapidly growing market in China and Mexico. The Chinese government is heavily funding research and installation of this up-and-coming technology, and a new generation of Chinese urologists is being trained to perform these procedures.

In Mexico, the growth of HIFU has been overwhelming, spurred by a public that is increasingly educated about options other than radical prostatectomy and a willingness to explore new treatments.

Meanwhile, cryoablation will also enjoy spectacular growth rates; however, this will not be attributed to demand for prostate cancer. Instead this market will be bolstered by its minimally invasive application for renal tumors, which is proving to be a big draw in Asia where kidney cancer rates are the highest in the world.

Millennium Research Group's Emerging Markets for Prostate Cancer Devices 2006 report includes in-depth analysis on the Chinese, Indian, Singaporean, South Korean, Taiwanese, Brazilian, and Mexican markets for brachytherapy seeds, cryoablation, and HIFU. The report includes insights into active competitors such as C.R. Bard (BCR), EDAP-TMS, Endocare (ENDO), Focus Surgery, Ningbo Junan, and Oncura.

A leading source of competitive intelligence, MRG is now the largest provider of medical device market research in the world. Located in Toronto, Canada, MRG covers global markets and has pioneered reporting of numerous emerging products.

MILLENNIUM RESEARCH GROUP
http://www.mrg.net





Cancer de prostatã dispozitiv de piaþã setat la triplu în Asia ºi America Latinã - Prostate Cancer Device Market Set To Triple In Asia And Latin America - articole medicale engleza - startsanatate